DK543488A - Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne - Google Patents

Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne

Info

Publication number
DK543488A
DK543488A DK543488A DK543488A DK543488A DK 543488 A DK543488 A DK 543488A DK 543488 A DK543488 A DK 543488A DK 543488 A DK543488 A DK 543488A DK 543488 A DK543488 A DK 543488A
Authority
DK
Denmark
Prior art keywords
mammal
gnrh
stimulating
vaccine
inhibit
Prior art date
Application number
DK543488A
Other languages
Danish (da)
English (en)
Other versions
DK543488D0 (da
Inventor
David W Silversides
Bruce D Murphy
Reuben J Mapletoft
Vikram Misra
Anne Francis Allen
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Publication of DK543488D0 publication Critical patent/DK543488D0/da
Publication of DK543488A publication Critical patent/DK543488A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/44—Antibodies bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/811—Drug, bio-affecting and body treating compositions involving sex selection or contraception

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK543488A 1987-09-30 1988-09-29 Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne DK543488A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/103,489 US4975420A (en) 1987-09-30 1987-09-30 Agents and procedures for provoking an immune response to GnRH and immuno sterilizing mammals

Publications (2)

Publication Number Publication Date
DK543488D0 DK543488D0 (da) 1988-09-29
DK543488A true DK543488A (da) 1989-03-31

Family

ID=22295467

Family Applications (1)

Application Number Title Priority Date Filing Date
DK543488A DK543488A (da) 1987-09-30 1988-09-29 Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne

Country Status (12)

Country Link
US (1) US4975420A (ja)
EP (1) EP0309863B1 (ja)
JP (1) JP2703574B2 (ja)
KR (1) KR890004730A (ja)
AT (1) ATE74516T1 (ja)
AU (1) AU605358B2 (ja)
CA (1) CA1335569C (ja)
DE (1) DE3869892D1 (ja)
DK (1) DK543488A (ja)
ES (1) ES2032917T3 (ja)
NZ (1) NZ226348A (ja)
ZA (1) ZA887304B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8713240D0 (en) * 1987-06-05 1987-07-08 Proteus Biotech Ltd Hormones
JPH0431072Y2 (ja) * 1988-03-14 1992-07-27
US5036047A (en) * 1988-09-29 1991-07-30 Pitman-Moore, Inc. Method and composition for preventing conception
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
PL296623A1 (en) * 1991-03-01 1993-09-20 Rhone Merieux Method of improving organoleptic properties of male slaughter animal meat
AU634379B2 (en) * 1991-04-29 1993-02-18 Csl Limited Recombinant immunocastration vaccine
CA2114125A1 (en) * 1991-07-26 1993-02-18 Wayne G. Reilly Self-adjuvanting peptide vaccine delivery system and production thereof
US5422110A (en) * 1991-10-16 1995-06-06 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5723129A (en) * 1991-10-16 1998-03-03 University Of Saskatchewan GnRH-leukotoxin chimeras
US6797272B1 (en) 1991-10-16 2004-09-28 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
AU2699192A (en) * 1991-10-16 1993-05-21 University Of Saskatchewan Enhanced immunogenicity using leukotoxin chimeras
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5759551A (en) * 1993-04-27 1998-06-02 United Biomedical, Inc. Immunogenic LHRH peptide constructs and synthetic universal immune stimulators for vaccines
US5491071A (en) * 1993-08-03 1996-02-13 Abbott Laboratories Reagents and methods for the detection and quantification of testosterone in fluid samples
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
JPH0824828A (ja) * 1994-07-08 1996-01-30 Hiromitsu Uchibori 生ゴミ処理悪臭消化の脱臭剤
WO1996004927A1 (en) * 1994-08-10 1996-02-22 Sandor Lovas NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF
US6664369B1 (en) * 1994-08-10 2003-12-16 Creighton University GnRH analogues with antitumour effects and pharmaceutical compositions thereof
AU7471796A (en) * 1995-10-27 1997-05-15 Merck & Co., Inc. Gnrh/reduced pseudomonas exotoxin conjugates
ES2233284T3 (es) * 1999-02-17 2005-06-16 Pfizer Products Inc. Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune.
CA2394670A1 (en) * 1999-12-13 2002-04-25 Universidad Nacional Autonoma De Mexico Immunoenzymatic quantification method
GB0000891D0 (en) * 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CL2009000900A1 (es) 2009-04-15 2009-08-14 Univ Chile Proteina de fusion que comprende la hormona liberadora de gonadotrofinas fusionada a una secuencia con capacidad inmunogenica con sitios de o-glicosilacion; secuencia de adn que la codifica; procedimiento de produccion; vacuna que las comprende; y su uso para inmunocastracion de mamiferos.
KR102583484B1 (ko) * 2016-02-01 2023-09-27 엘지전자 주식회사 수위 감지 장치 및 이를 포함하는 의류처리장치의 제어 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4302386A (en) * 1978-08-25 1981-11-24 The Ohio State University Antigenic modification of polypeptides
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
DE2735515A1 (de) * 1977-08-06 1979-02-22 Hoechst Ag Verwendung von lh-rh-peptiden als antikonzeptive
FR2522967B1 (fr) * 1982-03-15 1986-03-07 Anvar Conjugues d'haptenes et de muramyl-peptides, doues d'activite immunogene et compositions les contenant
US4618598A (en) * 1982-04-12 1986-10-21 Duke University Method of regulating hormone function or release
DE3371281D1 (en) * 1982-12-10 1987-06-11 Syntex Inc Lhrh preparations for intranasal administration
US4676981A (en) * 1984-02-07 1987-06-30 University Of Saskatchewan Monoclonal antibodies against GnRH
US4608251A (en) * 1984-11-09 1986-08-26 Pitman-Moore, Inc. LHRH analogues useful in stimulating anti-LHRH antibodies and vaccines containing such analogues

Also Published As

Publication number Publication date
AU2275588A (en) 1989-04-20
AU605358B2 (en) 1991-01-10
DE3869892D1 (de) 1992-05-14
JP2703574B2 (ja) 1998-01-26
ZA887304B (en) 1990-06-27
EP0309863B1 (de) 1992-04-08
NZ226348A (en) 1991-04-26
ATE74516T1 (de) 1992-04-15
EP0309863A2 (de) 1989-04-05
KR890004730A (ko) 1989-05-09
ES2032917T3 (es) 1996-07-16
US4975420A (en) 1990-12-04
EP0309863A3 (en) 1990-01-10
DK543488D0 (da) 1988-09-29
JPH02113A (ja) 1990-01-05
CA1335569C (en) 1995-05-16

Similar Documents

Publication Publication Date Title
DK543488A (da) Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne
DK693188D0 (da) Midler til stimulering af et pattedyrs immunreaktion over for gnrh samt et modificeret gnrh og en vaccine til inhibering af et pattedyrs reproduktionsevne
DE3679708D1 (de) Verfahren zur verleihung von immuntoleranz gegen ein spezifisches antigen.
DK0618813T3 (da) Antigen for M-hybridprotein og bærer for gruppe A streptococcal vaccine
DK0412486T3 (da) Antistoffer mod TNF-bindingsprotein I og F(ab)-fragmenter
ES2013328A6 (es) Un metodo para detectar anticuerpos contra antigenos hiv-1.
DK382989D0 (da) Cytotoxiske vinca-konjugater bundet til antistoffer og fremgangsmaade til fremstilling deraf
PT87688A (pt) Hybrid protein c and method for its preparation
ATE101345T1 (de) Selektive entfernung von immunkomplexen.
NO175639C (no) Peptid, antistoff oppnådd ved hjelp av peptidet, en fremgangsmåte for immunologisk bestemmelse av intakt prokollagen peptid (type III) og anvendelse av peptidet
ATE88901T1 (de) Fluorkohlenstoffkette enthaltende antigene konjugate.
DK0383599T3 (da) Protein-anticancermiddel
DE58904672D1 (de) Verfahren zur herstellung einer festphasenmatrix.
DE68917138T2 (de) Toleranzinduktion gegenüber einem fremdantigen.
EP0316818A3 (en) Monoclonal antibodies capable of recognizing n-acetylneuraminic acid in beta-arrangement
DE69014300D1 (de) Radioaktive markierung von proteinen.
NO983220L (no) Sammensetninger og fremgangsmåter for å administrere Borrelia Burgdorferi-antigener
IE860758L (en) Anaplasma marginale subunit antigen for vaccination and¹diagnosis
ATE175357T1 (de) Empfängnisverhütender impfstoff
SE8705137D0 (sv) Diagnostic method for primary biliary cirrhosis and antibodies suitable to be used in certain versions of the method
AU5217890A (en) Monoclonal antibodies in vaccine formulations
ES2074707T3 (es) Anticuerpos monoclonales que distinguen entre proteinas naturales y proteinas con secuencias modificadas.
IT8967056A0 (it) Procedimento di immunizzazione ma gnetica in particolare per mezzi navali
MX9707295A (es) Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10.
SU1692146A1 (ru) Штамм гибридных культивируемых клеток животных mus musculus l. - продуцент моноклональных антител к 146 s-компоненту вируса ящура o

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment